Skip to content
Screener

LivaNova LIVN Total Revenue

Total Revenue at other companies

Abbott logo
AbbottABT
$12.59B+13.0%
Haemonetics logo
HaemoneticsHAE
$339.38M+5.6%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$22.07M-2.0%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$204.58M+1.6%
Medtronic logo
MedtronicMDT
$9.81B+9.9%
ITG
Integer HoldingsITGR
$439.58M+0.5%

Segments

By segment

See full
Cardiopulmonary$221.58M+11.2%
Neuromodulation$166.95M+10.1%

By geography

See full
Rest of World$109.42M+12.5%
Europe$81.82M+22.5%

Other financials

Income statement

See full
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net revenue$390,587$352,524$752,845$669,379
Cost of sales116,917113,536235,426214,137
Gross profit273,670238,988517,419455,242
Operating expenses:
Selling, general, and administrative158,128137,780301,696266,926
Research and development53,66247,185112,35785,064
Other operating expense12,396(160)12,411452
Operating income49,48454,18390,955102,800

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's total revenue?
LivaNova (LIVN) reported total revenue of $390.59M in Q2 2026.
How has LivaNova's total revenue changed year-over-year?
LivaNova's total revenue increased by 10.8% year-over-year, from $352.52M to $390.59M.
What is the long-term trend for LivaNova's total revenue?
Over 4 years (2021 to 2025), LivaNova's total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $1.04B to $1.39B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about LivaNova's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude